Alex Gregory Sturmer

President, Chief Executive Officer & Director at Elysium Therapeutics, Inc.

Alex Gregory Sturmer

Alex Gregory Sturmer

President, Chief Executive Officer & Director at Elysium Therapeutics, Inc.

Biography

Alex Gregory Sturmer founded Elysium Therapeutics, Inc. Currently, Mr. Sturmer is President, Chief Executive Officer & Director at this company. He previously was Chief Financial Officer & Vice President of Signature Therapeutics, Inc. and Vice President-Finance of Innoviva, Inc. Mr. Sturmer received an MBA from Pepperdine University and an undergraduate degree from The California State University.

Overview
Career Highlights

Signature Therapeutics, Inc.
Elysium Therapeutics, Inc.

RelSci Relationships

75

Number of Boards

1

Birthday

1963

Age

56

Relationships
RelSci Relationships are individuals Alex Gregory Sturmer likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Scientific Officer & Director at Elysium Therapeutics, Inc.

Relationship likelihood: Strong

Former President at Nodality, Inc.

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Signature Therapeutics, Inc.

Relationship likelihood: Strong

Head-Finance at Signature Therapeutics, Inc.

Relationship likelihood: Average

Professor at Stanford University

Relationship likelihood: Average

Chief Medical Officer at Signature Therapeutics, Inc.

Relationship likelihood: Average

Executive Officer at Compound Holdings I LLC

Relationship likelihood: Average

Founder at Concentric Analgesics, Inc.

Relationship likelihood: Average

Founder at Concentric Analgesics, Inc.

Relationship likelihood: Average

Former Vice President-Intellectual Property at Signature Therapeutics, Inc.

Relationship likelihood: Weak

Paths to Alex Gregory Sturmer
Potential Connections via
Relationship Science
You
Alex Gregory Sturmer
President, Chief Executive Officer & Director at Elysium Therapeutics, Inc.
Education

Pepperdine is a Christian university committed to the highest standards of academic excellence and Christian values, where students are strengthened for lives of purpose, service, and leadership.

California State University, Long Beach (also known as Cal State Long Beach, Long Beach State, CSULB, LBSU, or The Beach) is the second largest campus of the 23 school California State University system (CSU) and one of the largest universities in the state of California by enrollment, its student body numbering 36,279 for the Fall 2012 semester.

Career History
President, Chief Executive Officer & Director
2013 - Current

Elysium Therapeutics, Inc. develops pain relievers. The company was founded by Alex Gregory Sturmer and Thomas E. Jenkins in 2013 and is headquartered in Danville, CA.

Vice President, Finance
1998 - Prior

Theravance is a biopharmaceutical company with a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical companies. Theravance is focused on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections, and central nervous system (CNS)/pain. The Company's key programs include: RELVAR™ or BREO™ ELLIPTA™(FF/VI), ANORO™ ELLIPTA™ (UMEC/VI) and MABA (Bifunctional Muscarinic Antagonist-Beta2 Agonist), each partnered with GlaxoSmithKline plc, and our oral Peripheral Mu Opioid Receptor Antagonist program. By leveraging its proprietary insight of multivalency to drug discovery, Theravance is pursuing a best-in-class strategy designed to discover superior medicines in areas of significant unmet medical need. Our objective is to discover, develop and commercialize new medicines with superior efficacy, convenience, tolerability and/or safety.

Chief Financial Officer & Vice President
Prior

Signature Therapeutics, Inc. develops and manufactures pharmaceutical products. It focuses on developing medications for use in pain management and ADHD. Its proprietary BIO-MD platform is designed to deter prescription drug abuse by virtue of strong chemical bonds within the prodrug and also offers solution to the ongoing epidemic of prescription opioid drug abuse. The company was founded by Steven L. Shafer in 2004 and is headquartered in Palo Alto, CA.

Transactions
Details Hidden

Elysium Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Elysium Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Elysium Therapeutics, Inc. raised money in a private placement transaction

Other Affiliations

Alex Gregory Sturmer is affiliated with Elysium Therapeutics, Inc., Innoviva, Inc., Signature Therapeutics, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Alex Gregory Sturmer. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Alex Gregory Sturmer's profile does not indicate a business or promotional relationship of any kind between RelSci and Alex Gregory Sturmer.